The prospects for the SARS ‐CoV‐2 pandemic in Africa
Open Access
- 5 May 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 12 (6), e12488
- https://doi.org/10.15252/emmm.202012488
Abstract
On December 31, 2019, the Chinese government officially announced the identification of a new type of coronavirus (SARS‐CoV‐2) as the etiological cause of a severe acute respiratory syndrome in Wuhan city, Hubei Province. Over the next weeks, SARS‐CoV‐2 caused a global pandemic as officially declared by the WHO on March 11, 2020, with confirmed cases and deaths in more than 166 countries. We are experiencing a worldwide phenomenon of unprecedented social and economic consequences. Since the beginning of the COVID‐19 outbreak, there have been fears that the epidemic could strongly impact weaker health‐care systems in poor‐resource settings, especially in Sub‐Saharan Africa (SSA). The 2 million Chinese nationals that live and work in Africa could potentially contribute to the spread of COVID‐19 on the continent.Keywords
This publication has 5 references indexed in Scilit:
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Embracing the Landscape of TherapeuticsCell, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South AmericaEpidemiology and Infection, 2020
- Hypertension in Blacks: Individualized Therapy Based on Renin/Aldosterone PhenotypingHypertension, 2018